*Dr. Gary Hellmann is not licensed to practice law. His activities are directly supervised by members of the firm licensed to practice law in the firm’s Winston-Salem office.
As a veteran Research Consultant for Womble Bond Dickinson Medical and Scientific Solutions, Gary combines extensive experience in molecular toxicology with a focus on toxicogenomics and the molecular basis of environmental and viral carcinogenesis. He consults with defense attorneys and expert witnesses to identify and understand relevant medical and scientific issues in litigation. He also consults on a broad range of epidemiological issues that often form the basis for defense strategies in toxic tort litigation.
Gary possesses a unique depth of knowledge and perspective gained from more than 35 years of experience in both academic and commercial settings and continues to maintain ties to the regional scientific community. Before joining the firm in 2004, Gary directed a molecular toxicology laboratory investigating molecular signatures in environmental carcinogenesis.
He is currently Adjunct Associate Professor of Physiology and Pharmacology at Wake Forest University where he lectures in toxicology and cancer biology. In addition, he has authored more than 30 peer-reviewed articles and book chapters is a co-author on a number of patents and is a reviewer for several scientific journals. As a teacher, Gary is skilled in presenting complex toxicological and biomedical issues in a manner that is understandable and applicable to legal settings. It is a distinct advantage to have an in-house scientist who speaks the same language as our experts.
Gary holds a Bachelor’s Degree from Centre College and both a Master’s Degree and Ph.D. from the University of Kentucky. He also holds a Master of Business Administration (MBA) from Wake Forest University.
Any result the lawyer or law firm may have achieved on behalf of clients in other matters does not necessarily indicate similar results can be obtained for other clients.
- As part of a multi-disciplinary team, prepared and filed a major regulatory submission document to FDA for a Fortune 500 client, and directed research supporting the drafting of industry comments in response to proposed FDA rules.
- Conducted a comprehensive review of scientific and biomedical literature in order to challenge claimed causal associations between certain occupational exposures and the onset of a neurological disease, and prepared a portfolio of cross-examination points for use with a plaintiff expert. As a result of combined efforts of counsel and the research team, a case against an American multinational tire and rubber manufacturer was withdrawn.
- Developed and crafted a series of comprehensive documents on disease causality and criteria, including epidemiology, laboratory studies and clinical data, by which causal associations between environmental exposure and disease outcomes may be either established or challenged.
- Has provided and continues to provide interpretation and evaluation of medical pathology reports, which have included immunohistochemical as well as genetic data, in assisting counsel in formulating effective defense strategies in toxic tort litigation matters.
- Regularly helps prepare expert witnesses for depositions and trial testimony in matters involving highly technical subjects.